Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERBB2 | P04626 | 2/20 | 0.54 |
| ▸ | MINK1 | Q8N4C8 | 1/20 | 0.54 |
| ▸ | LTA4H | P09960 | 1/20 | 0.48 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.48 |
| ▸ | FFAR1 | O14842 | 5/20 | 0.47 |
| ▸ | CYSLTR1 | Q9Y271 | 2/20 | 0.42 |
| ▸ | CYSLTR2 | Q9NS75 | 1/20 | 0.42 |
| ▸ | PPARA | Q07869 | 7/20 | 0.40 |
| ▸ | PPARG | P37231 | 6/20 | 0.40 |
| ▸ | LCK | P06239 | 1/20 | 0.38 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5758039 | 1.00 | ERBB2 (0.54) | ERBB2MINK1LTA4HEPHX2FFAR1 | |
| SCHEMBL5759664 | 0.99 | ERBB2 (0.53) | ERBB2MINK1LTA4HEPHX2FFAR1 | |
| SCHEMBL5760331 | 0.99 | ERBB2 (0.53) | ERBB2MINK1LTA4HEPHX2FFAR1 | |
| SCHEMBL5759709 | 0.99 | ERBB2 (0.53) | ERBB2MINK1LTA4HEPHX2FFAR1 | |
| SCHEMBL5760527 | 0.99 | ERBB2 (0.53) | ERBB2MINK1LTA4HEPHX2FFAR1 | |
| SCHEMBL5761322 | 0.97 | ERBB2 (0.52) | ERBB2MINK1LTA4HEPHX2FFAR1 | |
| SCHEMBL5761318 | 0.97 | ERBB2 (0.52) | ERBB2MINK1LTA4HEPHX2FFAR1 | |
| SCHEMBL5761665 | 0.92 | ERBB2 (0.49) | ERBB2MINK1LTA4HEPHX2FFAR1 | |
| SCHEMBL5761663 | 0.92 | ERBB2 (0.49) | ERBB2MINK1LTA4HEPHX2FFAR1 | |
| SCHEMBL6579741 | 0.89 | ERBB2 (0.54) | ERBB2MINK1LTA4HEPHX2FFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1270571-B1 | Heterocyclic compounds, their production and use | TAKEDA PHARMACEUTICAL (JP) | 2006-09-06 | — | — | EP | disclosed |
| US-20060135435-A1 | Agent that retards transformation of hormone-dependent cancer to non-hormone-dependent cancer | MATSUTANI ETSUYA | 2006-06-22 | — | — | US | disclosed |
| EP-1270571-A1 | Heterocyclic compounds, their production and use | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2003-01-02 | — | — | EP | disclosed |
| EP-1136079-A1 | AGENTS FOR RETARDING CHANGE OF HORMONE-DEPENDENT CANCER INTO HORMONE-INDEPENDENT CANCER | Takeda Chemical Industries, Ltd. (JP) | 2001-09-26 | — | — | EP | disclosed |
| US-6211215-B1 | AROMATIC HETEROCYCLIC COMPOUND WITH AZOLE COMPOUND | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2001-04-03 | — | — | US | disclosed |
| EP-0912562-A1 | HETEROCYCLIC COMPOUNDS, THEIR PRODUCTION AND USE | Takeda Chemical Industries, Ltd. (JP) | 1999-05-06 | — | — | EP | disclosed |
| WO-1998003505-A2 | HETEROCYCLIC COMPOUNDS, THEIR PRODUCTION AND USE | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1998-01-29 | — | — | WO | disclosed |